International Isotopes reports revenue bump for 2020

By staff writers

March 31, 2021 -- Radioisotope manufacturer International Isotopes reported a 5% increase in revenues for 2020.

In the period (end-December 31), total revenues were about $9.3 million compared with approximately $8.9 million in 2019. Sales grew 43% in the company's radiochemical segment thanks to U.S. Food and Drug Administration approval in February 2020 of its abbreviated new drug application for sodium iodide I-131.

The company also reached its highest level of net income in company history in 2020. Net income was about $2.2 million in 2020 compared with a net loss of approximately $1.5 million in 2019.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking